GemPharmatech Co., Ltd. (SHA:688046)

GemPharmatech Revenue

GemPharmatech had revenue of 208.08M CNY in the quarter ending March 31, 2026, with 21.79% growth. This brings the company's revenue in the last twelve months to 830.61M, up 18.56% year-over-year. In the year 2025, GemPharmatech had annual revenue of 793.39M with 15.51% growth.

• Revenue (ttm): 830.61M
• Revenue Growth: +18.56%
• P/S Ratio: 10.29
• Revenue / Employee: 526.37K
• Employees: 1,578
• Market Cap: 8.54B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	793.39M	106.55M	15.51%
Dec 31, 2024	686.84M	64.65M	10.39%
Dec 31, 2023	622.19M	105.64M	20.45%
Dec 31, 2022	516.55M	122.76M	31.17%
Dec 31, 2021	393.79M	131.87M	50.35%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 9, 2026

Data Sources Report a data error